Clinical Trials Browser

Interventional × Neoplasms × empagliflozin × Clear all

NCT06103279 2023-10-26

Cardioprotective Empagliflozin for Cancer Patients Receiving Doxorubicin

Phase 2/3 Unknown

Neoplasms